abstract |
【Task】 The present invention relates to the use of benzylideneaminoguanidine for the treatment of inflammation and pain. In one preferred embodiment, the present invention relates to the use of N- (2-chloro-3,4-dimethoxybenzylideneamino) guanidine for the treatment of rheumatoid arthritis. [Selection] Figure 1 |